|
2021
|
Invention
|
Treatment of demyelinating diseases. Described herein are methods of promoting remyelination in a... |
|
2019
|
Invention
|
Compositions and methods for intranasal delivery of pregnenolone.
This invention relates to meth... |
|
|
Invention
|
Compositions and methods for intranasal delivery of pregnenolone. This invention relates to metho... |
|
2018
|
Invention
|
Nasal pharmaceutical compositions for reducing the risks of exposure to air pollutants. Described... |
|
2017
|
Invention
|
Controlled release delivery system for nasal application of neurotransmitters.
This invention re... |
|
|
Invention
|
Nasal pharmaceutical compositions with a porous excipient. Described herein are nasal pharmaceuti... |
|
|
Invention
|
Nasal pharmaceutical compositions with a porous excipient.
Described herein are ... |
|
|
Invention
|
Controlled release delivery system for nasal applications and method of treatment. This invention... |
|
2015
|
Invention
|
Controlled release delivery system for nasal application of neurotransmitters. This invention rel... |
|
2012
|
Invention
|
Use of a container of an inorganic additive containing plastic material. The present invention re... |
|
|
Invention
|
Controlled release delivery system for nasal applications and methods of treatment. This inventio... |
|
2011
|
Invention
|
Controlled release delivery system for nasal applications. This invention relates to a pernasally... |
|
|
Invention
|
Nasal applicator |
